(2) EGFR-TKI could induce pericardial effusion due to cardiac toxicity, such as osimertinib and its metabolite AZ5104, which could induce myocardial injury via inhibiting HER2 (14). The gene discussed is ERBB2; the disease is pericardial effusion.